Want to join the conversation?
Latham, New York-based $ANGO said in 4Q16 the company successfully launched the new Asclera varicose and spider vein treatments and benefited from additional volume as a result of the Cook Medical recall. Growth in the Oncology/Surgery International business was driven by the approval of NanoKnife Probes in China.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?